For many decades it has been known that tumor DNA is shed into the blood. As a consequence of technological limitations, researchers were unable to comprehensively characterize circulating DNA. The advent of ultrasensitive and highly specific molecular assays has provided ...
Read More »Exosome Diagnostics Demonstrates Superior Mutation Detection Utilizing Combined Exosomal RNA (exoRNA) and Cell-Free DNA (cfDNA) Isolation and Analysis
BARCELONA, Spain and CAMBRIDGE, Mass.–(BUSINESS WIRE)–Exosome Diagnostics, Inc., a developer of revolutionary, biofluid-based molecular diagnostics, today announced new data demonstrating the ability of its technology platform to simultaneously isolate and analyze both exosomal RNA (exoRNA) and cell-free DNA (cfDNA) from ...
Read More »